Filing Details

Accession Number:
0001593968-21-002287
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-21 17:13:38
Reporting Period:
2021-01-25
Accepted Time:
2021-10-21 17:13:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
738214 Aemetis Inc AMTX Industrial Organic Chemicals (2860) 261407544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1285221 B Andrew Foster 20400 Stevens Crek Blvd, Suite 700
Cupertino CA 95014
Executive Vice President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-22 4,683 $18.58 23,862 No 4 F Direct
Common Stock Disposition 2021-04-19 10,500 $18.99 221,404 No 4 F Direct
Common Stock Disposition 2021-04-22 1,350 $18.58 32,382 No 4 F Direct
Common Stock Disposition 2021-04-19 9,058 $18.99 153,404 No 4 F Direct
Common Stock Disposition 2021-01-27 15,000 $7.77 5,235 No 4 S Direct
Common Stock Disposition 2021-01-28 10,000 $7.55 5,235 No 4 S Direct
Common Stock Disposition 2021-01-29 10,000 $6.57 5,235 No 4 S Direct
Common Stock Disposition 2021-02-01 10,000 $7.91 5,235 No 4 S Direct
Common Stock Disposition 2021-02-02 5,000 $7.53 5,235 No 4 S Direct
Common Stock Disposition 2021-03-15 1,681 $20.83 53,554 No 4 F Direct
Common Stock Disposition 2021-02-02 5,000 $8.00 5,235 No 4 S Direct
Common Stock Disposition 2021-02-03 10,000 $7.53 5,235 No 4 S Direct
Common Stock Disposition 2021-02-04 10,000 $7.86 5,235 No 4 S Direct
Common Stock Disposition 2021-02-05 10,000 $7.45 5,235 No 4 S Direct
Common Stock Disposition 2021-02-08 10,000 $7.59 5,235 No 4 S Direct
Common Stock Disposition 2021-01-26 5,000 $9.04 5,235 No 4 S Direct
Common Stock Disposition 2021-03-16 1,112 $19.21 90,361 No 4 F Direct
Common Stock Disposition 2021-04-19 1,696 $18.99 254,708 No 4 F Direct
Common Stock Disposition 2021-04-19 1,887 $18.99 45,190 No 4 F Direct
Common Stock Disposition 2021-03-15 1,081 $20.83 89,973 No 4 F Direct
Common Stock Disposition 2021-04-22 1,664 $18.58 40,718 No 4 F Direct
Common Stock Disposition 2021-01-25 10,000 $7.55 5,235 No 4 S Direct
Common Stock Disposition 2021-03-15 29,000 $19.92 60,973 No 4 S Direct
Common Stock Disposition 2021-03-16 32,800 $19.54 57,561 No 4 S Direct
Common Stock Disposition 2021-03-17 52,150 $18.92 5,411 No 4 S Direct
Common Stock Disposition 2021-04-19 2,728 $18.99 62,462 No 4 F Direct
Common Stock Disposition 2021-04-19 236,163 $18.65 18,545 No 4 S Direct
Common Stock Disposition 2021-04-20 10,000 $17.71 8,545 No 4 S Direct
Common Stock Disposition 2021-04-22 32,170 $19.40 8,548 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.
  2. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.
  3. These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.
  4. These shares were sold pursuant to a Rule 10b5-1 plan.